Medtronic
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medtronic generated cash of $6,787,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,450,000,000 last year. Net change in cash is therefore -$259,000,000.
Cash Flow
| 2015 | 4.90B | -17.05B | 15.94B |
|---|---|---|---|
| 2016 | 5.21B | 2.24B | -9.54B |
| 2017 | 6.88B | -1.57B | -3.28B |
| 2018 | 4.68B | 5.85B | -11.95B |
| 2019 | 7.00B | -774M | -5.43B |
| 2020 | 7.23B | -3.20B | -4.19B |
| 2021 | 6.24B | -2.86B | -4.13B |
| 2022 | 7.34B | -1.65B | -5.33B |
| 2023 | 6.03B | -3.49B | -4.96B |
| 2024 | 6.78B | -2.36B | -4.45B |
MDT Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.54B | 3.71B | 3.59B | 4.14B | 4.39B | 3.66B | 4.96B | 2.87B | 4.84B | 1.40B |
Operating activities | ||||||||||
Net income | 3.67B | 3.78B | 5.06B | 3.63B | 4.80B | 4.65B | 3.09B | 4.02B | 3.53B | 2.67B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.64B | 2.69B | 2.70B | 2.70B | 2.66B | 2.65B | 2.64B | 2.91B | 2.82B | 1.30B |
Stock-based compensation expense | 393M | 355M | 359M | 344M | 297M | 290M | 344M | 348M | 376M | 439M |
| Deferred income tax benefit | 393M | 355M | 359M | 344M | 297M | 290M | 344M | 348M | 376M | 439M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -391M | -576M | -477M | -761M | 1.29B | -581M | -275M | -75M | -435M | -413M |
Inventories | -139M | -939M | -560M | 78M | -577M | -274M | -192M | -227M | -186M | -282M |
Accounts payable | 391M | 696M | 213M | 531M | -44M | 399M | 65M | 356M | -65M | 1.61B |
Cash generated by operating activities | 6.78B | 6.03B | 7.34B | 6.24B | 7.23B | 7.00B | 4.68B | 6.88B | 5.21B | 4.90B |
Investing activities | ||||||||||
Purchases Of Investments | -7.74B | -7.51B | -9.88B | -11.80B | -11.03B | -2.53B | -3.2B | -4.37B | -5.40B | -7.58B |
Investments In Property Plant And Equipment | -1.58B | -1.45B | -1.36B | -1.35B | -1.21B | -1.13B | -1.06B | -1.25B | -1.04B | -571M |
Acquisitions Net | -211M | -1.86B | -91M | -994M | -488M | -1.82B | 5.92B | -1.32B | -1.21B | -14.88B |
Cash generated by investing activities | -2.36B | -3.49B | -1.65B | -2.86B | -3.20B | -774M | 5.85B | -1.57B | 2.24B | -17.05B |
Financing activities | ||||||||||
Common Stock Issued | 284M | 308M | 429M | 474M | 662M | 992M | 403M | 428M | 491M | 649M |
Payments for dividends | -3.66B | -3.61B | -3.38B | -3.12B | -2.89B | -2.69B | -2.49B | -2.37B | -2.13B | -1.33B |
Repurchases of common stock | -2.13B | -645M | -2.54B | -652M | -1.32B | -2.87B | -2.17B | -3.54B | -2.83B | -1.92B |
Repayments of term debt | 1.07B | -598M | -1M | -10.53B | -6.11B | -867M | -7.66B | 2.18B | -5.27B | 18.67B |
Cash used in financing activities | -4.45B | -4.96B | -5.33B | -4.13B | -4.19B | -5.43B | -11.95B | -3.28B | -9.54B | 15.94B |
Net Change In Cash | -259M | -2.17B | 121M | -547M | -253M | 724M | -1.29B | 2.09B | -1.96B | 3.44B |
Cash at end of period | 1.28B | 1.54B | 3.71B | 3.59B | 4.14B | 4.39B | 3.66B | 4.96B | 2.87B | 4.84B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |